| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diet | 23 | 2025 | 1140 | 3.720 |
Why?
|
| Diabetes Mellitus, Type 2 | 20 | 2025 | 1271 | 2.960 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 15 | 2014 | 224 | 2.910 |
Why?
|
| Feeding Behavior | 9 | 2021 | 702 | 2.530 |
Why?
|
| Pediatric Obesity | 6 | 2020 | 383 | 2.310 |
Why?
|
| Atherosclerosis | 21 | 2025 | 923 | 2.140 |
Why?
|
| Child Behavior | 5 | 2020 | 230 | 1.940 |
Why?
|
| Polymorphism, Single Nucleotide | 33 | 2025 | 2637 | 1.870 |
Why?
|
| Body Mass Index | 17 | 2023 | 1565 | 1.830 |
Why?
|
| Genome-Wide Association Study | 27 | 2023 | 1689 | 1.660 |
Why?
|
| Parenting | 4 | 2021 | 332 | 1.620 |
Why?
|
| Fatty Acids, Omega-3 | 9 | 2023 | 70 | 1.560 |
Why?
|
| Dairy Products | 6 | 2019 | 45 | 1.500 |
Why?
|
| Insulin Resistance | 11 | 2024 | 641 | 1.490 |
Why?
|
| Energy Intake | 9 | 2023 | 494 | 1.480 |
Why?
|
| Lipoproteins | 7 | 2017 | 180 | 1.470 |
Why?
|
| Metabolome | 2 | 2025 | 293 | 1.350 |
Why?
|
| Red Meat | 3 | 2025 | 6 | 1.300 |
Why?
|
| Persea | 3 | 2023 | 3 | 1.290 |
Why?
|
| Metabolomics | 3 | 2025 | 423 | 1.290 |
Why?
|
| Fenofibrate | 6 | 2018 | 59 | 1.270 |
Why?
|
| Cardiovascular Diseases | 15 | 2025 | 1970 | 1.230 |
Why?
|
| Humans | 156 | 2025 | 125269 | 1.210 |
Why?
|
| Motor Activity | 6 | 2017 | 520 | 1.200 |
Why?
|
| Diseases in Twins | 6 | 2014 | 94 | 1.170 |
Why?
|
| Vegetables | 5 | 2023 | 262 | 1.170 |
Why?
|
| Gene-Environment Interaction | 9 | 2025 | 122 | 1.160 |
Why?
|
| Linoleic Acid | 3 | 2023 | 16 | 1.150 |
Why?
|
| Fatty Acids | 8 | 2022 | 344 | 1.100 |
Why?
|
| Health Behavior | 3 | 2020 | 385 | 1.090 |
Why?
|
| Hypertension | 7 | 2025 | 1330 | 1.050 |
Why?
|
| Hypolipidemic Agents | 5 | 2015 | 182 | 1.010 |
Why?
|
| Cross-Sectional Studies | 20 | 2023 | 3432 | 0.990 |
Why?
|
| Risk Factors | 40 | 2025 | 10319 | 0.990 |
Why?
|
| Sweetening Agents | 3 | 2024 | 33 | 0.980 |
Why?
|
| Mendelian Randomization Analysis | 4 | 2019 | 84 | 0.970 |
Why?
|
| Middle Aged | 70 | 2025 | 26943 | 0.960 |
Why?
|
| Female | 100 | 2025 | 66844 | 0.960 |
Why?
|
| Life Style | 8 | 2019 | 416 | 0.960 |
Why?
|
| Obesity | 10 | 2023 | 2248 | 0.960 |
Why?
|
| Triglycerides | 8 | 2021 | 575 | 0.960 |
Why?
|
| Reaction Time | 7 | 2014 | 175 | 0.950 |
Why?
|
| Genetic Predisposition to Disease | 22 | 2020 | 3158 | 0.940 |
Why?
|
| Male | 96 | 2025 | 61560 | 0.930 |
Why?
|
| Twins | 7 | 2019 | 69 | 0.920 |
Why?
|
| Dietary Fats | 7 | 2019 | 294 | 0.910 |
Why?
|
| Aged | 55 | 2025 | 19881 | 0.890 |
Why?
|
| Lipid Metabolism | 4 | 2019 | 357 | 0.890 |
Why?
|
| Sleep | 9 | 2025 | 345 | 0.880 |
Why?
|
| Adiposity | 2 | 2022 | 190 | 0.870 |
Why?
|
| Satiation | 2 | 2018 | 23 | 0.830 |
Why?
|
| Child Nutritional Physiological Phenomena | 3 | 2018 | 173 | 0.830 |
Why?
|
| Child Care | 1 | 2023 | 11 | 0.830 |
Why?
|
| Nutrition Policy | 2 | 2018 | 102 | 0.810 |
Why?
|
| Cholesterol, LDL | 5 | 2020 | 571 | 0.810 |
Why?
|
| Schools | 3 | 2023 | 219 | 0.800 |
Why?
|
| Blood Glucose | 12 | 2024 | 1131 | 0.790 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 3 | 2012 | 44 | 0.790 |
Why?
|
| Fatty Acids, Omega-6 | 2 | 2023 | 16 | 0.780 |
Why?
|
| Glutamine | 1 | 2023 | 215 | 0.770 |
Why?
|
| Precision Medicine | 1 | 2025 | 319 | 0.770 |
Why?
|
| Child | 37 | 2025 | 24431 | 0.760 |
Why?
|
| Cause of Death | 3 | 2021 | 476 | 0.740 |
Why?
|
| Postmenopause | 4 | 2021 | 126 | 0.730 |
Why?
|
| Beverages | 2 | 2018 | 100 | 0.720 |
Why?
|
| Phenotype | 15 | 2020 | 4262 | 0.720 |
Why?
|
| Insulin | 11 | 2024 | 1203 | 0.720 |
Why?
|
| Intelligence | 4 | 2012 | 98 | 0.700 |
Why?
|
| Oxyhemoglobins | 2 | 2019 | 24 | 0.690 |
Why?
|
| Weight Gain | 4 | 2021 | 400 | 0.690 |
Why?
|
| Cholesterol, HDL | 6 | 2025 | 358 | 0.690 |
Why?
|
| Sleep Apnea Syndromes | 3 | 2019 | 73 | 0.680 |
Why?
|
| Neuropsychological Tests | 8 | 2024 | 919 | 0.650 |
Why?
|
| Cognition Disorders | 4 | 2014 | 550 | 0.640 |
Why?
|
| Lipids | 4 | 2018 | 523 | 0.630 |
Why?
|
| Child Nutrition Sciences | 1 | 2019 | 19 | 0.630 |
Why?
|
| Health Promotion | 3 | 2018 | 389 | 0.630 |
Why?
|
| Craniosynostoses | 1 | 2021 | 132 | 0.620 |
Why?
|
| Executive Function | 1 | 2019 | 109 | 0.610 |
Why?
|
| Infant Formula | 1 | 2019 | 96 | 0.600 |
Why?
|
| Exploratory Behavior | 1 | 2018 | 53 | 0.600 |
Why?
|
| Risk-Taking | 1 | 2019 | 96 | 0.600 |
Why?
|
| Nutrition Surveys | 4 | 2023 | 293 | 0.590 |
Why?
|
| Child Health | 1 | 2018 | 53 | 0.590 |
Why?
|
| Cohort Studies | 21 | 2022 | 4818 | 0.590 |
Why?
|
| Genotype | 14 | 2025 | 2566 | 0.580 |
Why?
|
| Parents | 5 | 2023 | 1026 | 0.580 |
Why?
|
| Prospective Studies | 23 | 2025 | 6158 | 0.580 |
Why?
|
| Diet, Mediterranean | 3 | 2020 | 13 | 0.580 |
Why?
|
| Adult | 38 | 2024 | 29652 | 0.580 |
Why?
|
| United States | 24 | 2025 | 10918 | 0.570 |
Why?
|
| Appetite Regulation | 3 | 2020 | 41 | 0.560 |
Why?
|
| Nutritional Status | 4 | 2022 | 315 | 0.560 |
Why?
|
| Age Factors | 9 | 2020 | 2825 | 0.560 |
Why?
|
| Aged, 80 and over | 22 | 2025 | 6603 | 0.550 |
Why?
|
| Vitamin D | 4 | 2019 | 161 | 0.550 |
Why?
|
| Dietary Proteins | 4 | 2025 | 252 | 0.550 |
Why?
|
| Proportional Hazards Models | 11 | 2025 | 1360 | 0.550 |
Why?
|
| Social Environment | 4 | 2010 | 120 | 0.550 |
Why?
|
| Coronary Disease | 4 | 2024 | 678 | 0.550 |
Why?
|
| Dietary Approaches To Stop Hypertension | 3 | 2022 | 6 | 0.550 |
Why?
|
| Angiopoietin-2 | 1 | 2016 | 13 | 0.540 |
Why?
|
| Coffee | 2 | 2017 | 24 | 0.540 |
Why?
|
| Smoking | 5 | 2019 | 1051 | 0.530 |
Why?
|
| Overweight | 1 | 2019 | 364 | 0.520 |
Why?
|
| Pediatrics | 3 | 2022 | 1152 | 0.520 |
Why?
|
| Milk, Human | 1 | 2019 | 300 | 0.520 |
Why?
|
| Diet, High-Fat | 2 | 2015 | 211 | 0.520 |
Why?
|
| Actigraphy | 5 | 2025 | 45 | 0.510 |
Why?
|
| Asymptomatic Diseases | 2 | 2024 | 82 | 0.510 |
Why?
|
| Risk Assessment | 9 | 2025 | 3465 | 0.500 |
Why?
|
| Cognition | 6 | 2024 | 728 | 0.500 |
Why?
|
| Oxygen Consumption | 1 | 2016 | 305 | 0.500 |
Why?
|
| Impulsive Behavior | 3 | 2014 | 145 | 0.490 |
Why?
|
| Genetic Variation | 7 | 2021 | 1502 | 0.490 |
Why?
|
| Vascular Calcification | 2 | 2024 | 57 | 0.470 |
Why?
|
| Caregivers | 1 | 2020 | 578 | 0.460 |
Why?
|
| Eating | 3 | 2024 | 368 | 0.450 |
Why?
|
| Multivariate Analysis | 9 | 2024 | 1439 | 0.440 |
Why?
|
| Psychomotor Performance | 2 | 2012 | 182 | 0.440 |
Why?
|
| Risk Reduction Behavior | 3 | 2019 | 145 | 0.430 |
Why?
|
| Microbiota | 3 | 2024 | 389 | 0.430 |
Why?
|
| Exercise | 3 | 2025 | 816 | 0.430 |
Why?
|
| Child, Preschool | 13 | 2025 | 14029 | 0.430 |
Why?
|
| Genetic Loci | 4 | 2022 | 339 | 0.420 |
Why?
|
| Biomedical Research | 1 | 2019 | 519 | 0.420 |
Why?
|
| Adolescent | 19 | 2025 | 19362 | 0.420 |
Why?
|
| Self Report | 2 | 2018 | 517 | 0.410 |
Why?
|
| Primary Prevention | 2 | 2019 | 172 | 0.400 |
Why?
|
| Personality Assessment | 2 | 2010 | 105 | 0.400 |
Why?
|
| Infant | 8 | 2025 | 12517 | 0.400 |
Why?
|
| Urogenital Abnormalities | 2 | 2025 | 154 | 0.390 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 3 | 2013 | 31 | 0.390 |
Why?
|
| Genetic Association Studies | 6 | 2016 | 779 | 0.390 |
Why?
|
| Chromosomes, Human, Pair 12 | 2 | 2012 | 92 | 0.380 |
Why?
|
| Calcium | 2 | 2017 | 1102 | 0.380 |
Why?
|
| Coronary Artery Disease | 3 | 2024 | 814 | 0.380 |
Why?
|
| Blood Pressure | 3 | 2025 | 1375 | 0.370 |
Why?
|
| Meat | 3 | 2023 | 48 | 0.370 |
Why?
|
| Incidence | 11 | 2025 | 3148 | 0.370 |
Why?
|
| Inflammation | 3 | 2023 | 1446 | 0.370 |
Why?
|
| Lipoproteins, VLDL | 3 | 2014 | 58 | 0.360 |
Why?
|
| Models, Genetic | 5 | 2019 | 760 | 0.360 |
Why?
|
| DNA Methylation | 5 | 2020 | 1007 | 0.360 |
Why?
|
| Linkage Disequilibrium | 3 | 2018 | 309 | 0.360 |
Why?
|
| Sex Factors | 7 | 2025 | 1289 | 0.360 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2019 | 206 | 0.360 |
Why?
|
| Body Weight | 4 | 2024 | 989 | 0.350 |
Why?
|
| Electrophysiology | 2 | 2008 | 271 | 0.350 |
Why?
|
| Sleep, REM | 3 | 2020 | 25 | 0.350 |
Why?
|
| Biomarkers | 12 | 2023 | 3091 | 0.340 |
Why?
|
| Postprandial Period | 3 | 2015 | 77 | 0.340 |
Why?
|
| Urinary Tract Infections | 2 | 2025 | 298 | 0.340 |
Why?
|
| Energy Metabolism | 1 | 2015 | 766 | 0.340 |
Why?
|
| Twins, Dizygotic | 5 | 2017 | 42 | 0.330 |
Why?
|
| Dementia | 2 | 2024 | 452 | 0.320 |
Why?
|
| Twins, Monozygotic | 5 | 2017 | 117 | 0.320 |
Why?
|
| Homeostasis | 5 | 2024 | 703 | 0.310 |
Why?
|
| Surveys and Questionnaires | 8 | 2021 | 3738 | 0.310 |
Why?
|
| Choice Behavior | 5 | 2018 | 132 | 0.310 |
Why?
|
| Docosahexaenoic Acids | 5 | 2023 | 68 | 0.310 |
Why?
|
| Body Composition | 2 | 2019 | 521 | 0.310 |
Why?
|
| Lipoproteins, LDL | 2 | 2014 | 129 | 0.300 |
Why?
|
| Motion | 1 | 2008 | 43 | 0.300 |
Why?
|
| Disruptive, Impulse Control, and Conduct Disorders | 1 | 2008 | 32 | 0.300 |
Why?
|
| Arachidonic Acid | 2 | 2019 | 82 | 0.290 |
Why?
|
| Genetic Linkage | 2 | 2016 | 453 | 0.290 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2021 | 177 | 0.290 |
Why?
|
| ROC Curve | 1 | 2009 | 571 | 0.280 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 244 | 0.280 |
Why?
|
| Shyness | 1 | 2017 | 1 | 0.280 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2019 | 92 | 0.280 |
Why?
|
| Temperament | 1 | 2007 | 26 | 0.280 |
Why?
|
| Fatty Acids, Unsaturated | 4 | 2023 | 65 | 0.280 |
Why?
|
| Lactase | 1 | 2017 | 40 | 0.270 |
Why?
|
| Diet Surveys | 1 | 2017 | 98 | 0.270 |
Why?
|
| Ankle Brachial Index | 2 | 2024 | 42 | 0.270 |
Why?
|
| Tea | 1 | 2016 | 15 | 0.270 |
Why?
|
| Attention | 2 | 2014 | 201 | 0.270 |
Why?
|
| Epigenesis, Genetic | 2 | 2019 | 678 | 0.260 |
Why?
|
| Carotid Intima-Media Thickness | 2 | 2024 | 75 | 0.260 |
Why?
|
| Affect | 1 | 2017 | 158 | 0.260 |
Why?
|
| Caffeine | 1 | 2016 | 71 | 0.250 |
Why?
|
| Observer Variation | 2 | 2012 | 299 | 0.250 |
Why?
|
| Body Fat Distribution | 1 | 2015 | 29 | 0.250 |
Why?
|
| Diabetes Mellitus | 3 | 2023 | 874 | 0.250 |
Why?
|
| Lipoproteins, HDL | 2 | 2012 | 100 | 0.250 |
Why?
|
| Acculturation | 1 | 2016 | 68 | 0.240 |
Why?
|
| Fruit | 2 | 2023 | 220 | 0.240 |
Why?
|
| Particle Size | 2 | 2012 | 124 | 0.240 |
Why?
|
| Odds Ratio | 4 | 2024 | 1259 | 0.240 |
Why?
|
| Reactive Inhibition | 1 | 2014 | 3 | 0.240 |
Why?
|
| Xylitol | 1 | 2024 | 4 | 0.230 |
Why?
|
| CLOCK Proteins | 1 | 2014 | 28 | 0.230 |
Why?
|
| Chewing Gum | 1 | 2024 | 9 | 0.230 |
Why?
|
| Glucose | 3 | 2024 | 877 | 0.230 |
Why?
|
| Fatty Acid Desaturases | 2 | 2021 | 8 | 0.230 |
Why?
|
| Environment | 2 | 2019 | 145 | 0.230 |
Why?
|
| Dietary Supplements | 2 | 2019 | 472 | 0.230 |
Why?
|
| Periodontal Diseases | 1 | 2024 | 25 | 0.230 |
Why?
|
| Quantitative Trait Loci | 4 | 2019 | 287 | 0.230 |
Why?
|
| alpha-Linolenic Acid | 3 | 2023 | 15 | 0.220 |
Why?
|
| Flavonoids | 1 | 2024 | 78 | 0.220 |
Why?
|
| Family | 2 | 2021 | 566 | 0.220 |
Why?
|
| Meals | 2 | 2015 | 57 | 0.220 |
Why?
|
| Metagenomics | 1 | 2024 | 102 | 0.220 |
Why?
|
| Binge Drinking | 1 | 2023 | 10 | 0.220 |
Why?
|
| Cholesterol | 2 | 2013 | 541 | 0.210 |
Why?
|
| Heart Diseases | 2 | 2018 | 495 | 0.210 |
Why?
|
| Computers | 1 | 2013 | 68 | 0.210 |
Why?
|
| Infant, Newborn | 6 | 2025 | 8236 | 0.210 |
Why?
|
| Urinary Tract | 1 | 2024 | 60 | 0.210 |
Why?
|
| Prediabetic State | 1 | 2024 | 58 | 0.210 |
Why?
|
| Aging | 3 | 2020 | 1181 | 0.210 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2024 | 81 | 0.210 |
Why?
|
| Child Day Care Centers | 1 | 2023 | 26 | 0.210 |
Why?
|
| Carotid Artery Diseases | 1 | 2024 | 148 | 0.210 |
Why?
|
| Parent-Child Relations | 2 | 2021 | 248 | 0.210 |
Why?
|
| Sleep Hygiene | 1 | 2023 | 9 | 0.210 |
Why?
|
| Meta-Analysis as Topic | 3 | 2021 | 161 | 0.210 |
Why?
|
| Protective Factors | 4 | 2024 | 85 | 0.200 |
Why?
|
| Television | 1 | 2013 | 71 | 0.200 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2024 | 140 | 0.200 |
Why?
|
| Siblings | 5 | 2012 | 196 | 0.200 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2012 | 43 | 0.200 |
Why?
|
| Calcinosis | 1 | 2024 | 179 | 0.200 |
Why?
|
| Heredity | 2 | 2021 | 15 | 0.200 |
Why?
|
| Fasting | 3 | 2017 | 294 | 0.200 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2013 | 294 | 0.200 |
Why?
|
| Trans Fatty Acids | 1 | 2022 | 10 | 0.200 |
Why?
|
| Adiponectin | 1 | 2012 | 114 | 0.190 |
Why?
|
| Recommended Dietary Allowances | 2 | 2019 | 23 | 0.190 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2022 | 1 | 0.190 |
Why?
|
| Patient Compliance | 1 | 2015 | 473 | 0.190 |
Why?
|
| Metformin | 1 | 2024 | 151 | 0.190 |
Why?
|
| Family Characteristics | 1 | 2012 | 79 | 0.190 |
Why?
|
| PPAR alpha | 1 | 2012 | 51 | 0.190 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 398 | 0.190 |
Why?
|
| Drug Resistance | 1 | 2012 | 257 | 0.190 |
Why?
|
| Regression Analysis | 4 | 2018 | 781 | 0.190 |
Why?
|
| Psychometrics | 3 | 2010 | 673 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2012 | 49 | 0.190 |
Why?
|
| Fibroblast Growth Factors | 3 | 2018 | 152 | 0.190 |
Why?
|
| Waist-Hip Ratio | 1 | 2022 | 56 | 0.190 |
Why?
|
| Nutritive Value | 2 | 2019 | 91 | 0.190 |
Why?
|
| Nutritionists | 1 | 2021 | 8 | 0.190 |
Why?
|
| Airway Obstruction | 1 | 2023 | 165 | 0.190 |
Why?
|
| Cadherins | 1 | 2012 | 171 | 0.190 |
Why?
|
| Adrenal Insufficiency | 1 | 2021 | 28 | 0.190 |
Why?
|
| Hypertriglyceridemia | 1 | 2012 | 104 | 0.180 |
Why?
|
| Indians, North American | 1 | 2021 | 58 | 0.180 |
Why?
|
| Alcohol Drinking | 2 | 2019 | 346 | 0.180 |
Why?
|
| Chromosome Mapping | 3 | 2019 | 1078 | 0.180 |
Why?
|
| Mortality, Premature | 1 | 2021 | 12 | 0.180 |
Why?
|
| Metabolic Syndrome | 2 | 2020 | 343 | 0.180 |
Why?
|
| Patient Satisfaction | 2 | 2022 | 476 | 0.180 |
Why?
|
| Public Health | 1 | 2023 | 267 | 0.180 |
Why?
|
| American Heart Association | 2 | 2020 | 322 | 0.180 |
Why?
|
| Aortic Valve | 1 | 2024 | 442 | 0.180 |
Why?
|
| Pseudotumor Cerebri | 1 | 2021 | 58 | 0.180 |
Why?
|
| Pedigree | 3 | 2018 | 1606 | 0.170 |
Why?
|
| Fatty Acids, Monounsaturated | 2 | 2018 | 48 | 0.170 |
Why?
|
| Gadolinium | 1 | 2021 | 108 | 0.170 |
Why?
|
| Salivary alpha-Amylases | 1 | 2020 | 2 | 0.170 |
Why?
|
| Multigene Family | 1 | 2021 | 299 | 0.170 |
Why?
|
| Alleles | 6 | 2025 | 1614 | 0.170 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 5180 | 0.170 |
Why?
|
| Premature Birth | 1 | 2024 | 387 | 0.170 |
Why?
|
| Satiety Response | 1 | 2020 | 30 | 0.170 |
Why?
|
| Self-Control | 1 | 2020 | 16 | 0.170 |
Why?
|
| Hunger | 1 | 2020 | 46 | 0.170 |
Why?
|
| Aortic Valve Stenosis | 1 | 2024 | 336 | 0.170 |
Why?
|
| Methylphenidate | 1 | 2020 | 58 | 0.170 |
Why?
|
| Lipogenesis | 1 | 2020 | 56 | 0.170 |
Why?
|
| Individuality | 2 | 2010 | 34 | 0.170 |
Why?
|
| Biological Specimen Banks | 1 | 2020 | 51 | 0.170 |
Why?
|
| Cues | 1 | 2020 | 93 | 0.170 |
Why?
|
| Education, Distance | 1 | 2020 | 64 | 0.170 |
Why?
|
| Alcoholism | 2 | 2019 | 231 | 0.160 |
Why?
|
| Bacteremia | 1 | 2024 | 407 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2012 | 369 | 0.160 |
Why?
|
| Comorbidity | 5 | 2019 | 1535 | 0.160 |
Why?
|
| Hypothalamic Diseases | 1 | 2020 | 37 | 0.160 |
Why?
|
| Emotions | 1 | 2012 | 357 | 0.160 |
Why?
|
| Stroke | 2 | 2024 | 989 | 0.160 |
Why?
|
| Interleukin-18 Receptor alpha Subunit | 1 | 2019 | 1 | 0.160 |
Why?
|
| Gene Frequency | 5 | 2017 | 724 | 0.160 |
Why?
|
| Eicosanoic Acids | 1 | 2019 | 2 | 0.160 |
Why?
|
| Central Nervous System Stimulants | 1 | 2020 | 127 | 0.160 |
Why?
|
| Hexokinase | 1 | 2019 | 21 | 0.160 |
Why?
|
| Ferrochelatase | 1 | 2019 | 2 | 0.160 |
Why?
|
| Infant Food | 1 | 2019 | 81 | 0.160 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2019 | 17 | 0.160 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2019 | 19 | 0.160 |
Why?
|
| Leukocytes | 1 | 2020 | 211 | 0.160 |
Why?
|
| Inheritance Patterns | 1 | 2019 | 127 | 0.150 |
Why?
|
| Young Adult | 6 | 2024 | 9056 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2025 | 731 | 0.150 |
Why?
|
| Government Regulation | 1 | 2018 | 41 | 0.150 |
Why?
|
| Mothers | 1 | 2021 | 355 | 0.150 |
Why?
|
| Genome, Human | 3 | 2019 | 1273 | 0.150 |
Why?
|
| Policy Making | 1 | 2018 | 59 | 0.150 |
Why?
|
| Genetics, Population | 1 | 2019 | 188 | 0.150 |
Why?
|
| Multifactorial Inheritance | 1 | 2019 | 139 | 0.150 |
Why?
|
| Genes | 1 | 2019 | 447 | 0.150 |
Why?
|
| Cerebrovascular Disorders | 1 | 2019 | 122 | 0.150 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2019 | 193 | 0.140 |
Why?
|
| Respiratory Function Tests | 1 | 2018 | 199 | 0.140 |
Why?
|
| Potassium | 1 | 2019 | 283 | 0.140 |
Why?
|
| Breast Feeding | 1 | 2019 | 221 | 0.140 |
Why?
|
| Food Preferences | 1 | 2018 | 117 | 0.140 |
Why?
|
| Family Health | 2 | 2009 | 259 | 0.140 |
Why?
|
| C-Reactive Protein | 3 | 2023 | 432 | 0.140 |
Why?
|
| Birth Weight | 1 | 2019 | 345 | 0.140 |
Why?
|
| Models, Psychological | 2 | 2017 | 138 | 0.140 |
Why?
|
| Sodium | 1 | 2019 | 298 | 0.140 |
Why?
|
| CpG Islands | 2 | 2020 | 323 | 0.140 |
Why?
|
| Europe | 3 | 2018 | 355 | 0.140 |
Why?
|
| Pandemics | 2 | 2022 | 1111 | 0.140 |
Why?
|
| Observational Studies as Topic | 3 | 2019 | 88 | 0.140 |
Why?
|
| Cost of Illness | 1 | 2018 | 252 | 0.140 |
Why?
|
| Cancer Survivors | 1 | 2020 | 211 | 0.130 |
Why?
|
| Vesicular Transport Proteins | 1 | 2018 | 120 | 0.130 |
Why?
|
| Socioeconomic Factors | 4 | 2019 | 872 | 0.130 |
Why?
|
| Oxygen | 2 | 2019 | 557 | 0.130 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 604 | 0.130 |
Why?
|
| Statistics as Topic | 1 | 2017 | 256 | 0.130 |
Why?
|
| Animals | 6 | 2024 | 34238 | 0.130 |
Why?
|
| Glioma | 1 | 2021 | 492 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 2 | 2025 | 2433 | 0.130 |
Why?
|
| Diet Records | 2 | 2017 | 74 | 0.130 |
Why?
|
| Weight Loss | 1 | 2020 | 481 | 0.130 |
Why?
|
| Respiration | 1 | 2016 | 122 | 0.130 |
Why?
|
| Telemedicine | 1 | 2022 | 437 | 0.130 |
Why?
|
| Models, Statistical | 2 | 2009 | 471 | 0.130 |
Why?
|
| Meat Products | 1 | 2015 | 5 | 0.130 |
Why?
|
| Stomach Neoplasms | 1 | 2022 | 548 | 0.120 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2015 | 8 | 0.120 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2015 | 42 | 0.120 |
Why?
|
| Hyperinsulinism | 1 | 2015 | 67 | 0.120 |
Why?
|
| Echocardiography | 1 | 2020 | 1056 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2019 | 1506 | 0.120 |
Why?
|
| Cardiology | 1 | 2020 | 507 | 0.120 |
Why?
|
| Lung | 2 | 2023 | 1496 | 0.120 |
Why?
|
| Atrial Fibrillation | 1 | 2022 | 660 | 0.120 |
Why?
|
| Haplotypes | 1 | 2016 | 522 | 0.120 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2012 | 213 | 0.120 |
Why?
|
| DNA Copy Number Variations | 1 | 2020 | 949 | 0.120 |
Why?
|
| Peripheral Arterial Disease | 1 | 2018 | 292 | 0.120 |
Why?
|
| Lung Diseases | 1 | 2018 | 384 | 0.120 |
Why?
|
| Databases, Factual | 1 | 2019 | 1180 | 0.110 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 724 | 0.110 |
Why?
|
| Polymorphism, Genetic | 1 | 2017 | 816 | 0.110 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2014 | 25 | 0.110 |
Why?
|
| Case-Control Studies | 4 | 2020 | 3304 | 0.110 |
Why?
|
| Insulin-Secreting Cells | 1 | 2015 | 148 | 0.110 |
Why?
|
| Nutrition Assessment | 2 | 2015 | 136 | 0.110 |
Why?
|
| Diagnosis, Differential | 2 | 2009 | 1898 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 854 | 0.110 |
Why?
|
| Twin Studies as Topic | 2 | 2010 | 15 | 0.110 |
Why?
|
| Australia | 2 | 2018 | 137 | 0.110 |
Why?
|
| Insulin, Regular, Human | 2 | 2024 | 11 | 0.110 |
Why?
|
| Heart | 1 | 2018 | 730 | 0.110 |
Why?
|
| Clinical Competence | 1 | 2020 | 1008 | 0.110 |
Why?
|
| Hyperglycemia | 1 | 2015 | 226 | 0.110 |
Why?
|
| Adipose Tissue | 3 | 2023 | 465 | 0.110 |
Why?
|
| Time Factors | 4 | 2024 | 6339 | 0.110 |
Why?
|
| Linear Models | 2 | 2016 | 684 | 0.100 |
Why?
|
| Chylomicrons | 1 | 2013 | 9 | 0.100 |
Why?
|
| Longitudinal Studies | 3 | 2023 | 1327 | 0.100 |
Why?
|
| Internal-External Control | 2 | 2010 | 75 | 0.100 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 702 | 0.100 |
Why?
|
| Dietary Carbohydrates | 1 | 2013 | 119 | 0.100 |
Why?
|
| Intestinal Absorption | 1 | 2013 | 190 | 0.100 |
Why?
|
| Helicobacter pylori | 1 | 2022 | 1324 | 0.100 |
Why?
|
| Helicobacter Infections | 1 | 2022 | 1267 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2019 | 829 | 0.100 |
Why?
|
| Apolipoproteins E | 2 | 2012 | 192 | 0.090 |
Why?
|
| Waist Circumference | 2 | 2015 | 89 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2020 | 1216 | 0.090 |
Why?
|
| Nonlinear Dynamics | 1 | 2010 | 51 | 0.080 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 689 | 0.080 |
Why?
|
| Genetic Research | 1 | 2010 | 55 | 0.080 |
Why?
|
| Wales | 1 | 2009 | 5 | 0.080 |
Why?
|
| England | 1 | 2009 | 59 | 0.080 |
Why?
|
| Bias | 1 | 2010 | 133 | 0.080 |
Why?
|
| Reward | 1 | 2010 | 111 | 0.080 |
Why?
|
| Eicosapentaenoic Acid | 2 | 2021 | 81 | 0.080 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2009 | 105 | 0.080 |
Why?
|
| Retrospective Studies | 6 | 2025 | 16360 | 0.080 |
Why?
|
| Utah | 2 | 2013 | 47 | 0.080 |
Why?
|
| Principal Component Analysis | 1 | 2009 | 141 | 0.080 |
Why?
|
| Vital Capacity | 2 | 2019 | 76 | 0.080 |
Why?
|
| Minnesota | 2 | 2013 | 133 | 0.080 |
Why?
|
| Australian Capital Territory | 1 | 2017 | 1 | 0.070 |
Why?
|
| Reference Values | 1 | 2009 | 718 | 0.070 |
Why?
|
| Forced Expiratory Volume | 2 | 2019 | 171 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2018 | 2593 | 0.070 |
Why?
|
| Polysomnography | 2 | 2019 | 146 | 0.070 |
Why?
|
| Depression | 1 | 2016 | 1237 | 0.070 |
Why?
|
| Likelihood Functions | 1 | 2017 | 114 | 0.070 |
Why?
|
| Prognosis | 3 | 2020 | 4646 | 0.070 |
Why?
|
| Calcium, Dietary | 1 | 2016 | 37 | 0.060 |
Why?
|
| Research Design | 1 | 2010 | 695 | 0.060 |
Why?
|
| Fear | 1 | 2017 | 199 | 0.060 |
Why?
|
| Food Handling | 1 | 2015 | 18 | 0.060 |
Why?
|
| Heart Failure | 1 | 2019 | 2299 | 0.060 |
Why?
|
| Subcutaneous Fat | 1 | 2015 | 29 | 0.060 |
Why?
|
| Sodium, Dietary | 1 | 2015 | 36 | 0.060 |
Why?
|
| Intra-Abdominal Fat | 1 | 2015 | 52 | 0.060 |
Why?
|
| Edible Grain | 1 | 2015 | 45 | 0.060 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 369 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 1016 | 0.060 |
Why?
|
| North Carolina | 1 | 2015 | 59 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2014 | 817 | 0.060 |
Why?
|
| Dietary Fiber | 1 | 2015 | 75 | 0.060 |
Why?
|
| Population Surveillance | 1 | 2007 | 389 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 1056 | 0.060 |
Why?
|
| Apolipoprotein E4 | 1 | 2024 | 45 | 0.060 |
Why?
|
| Metals | 1 | 2024 | 63 | 0.060 |
Why?
|
| Fatty Acids, Volatile | 1 | 2024 | 33 | 0.060 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2024 | 76 | 0.060 |
Why?
|
| Brain | 3 | 2021 | 3004 | 0.050 |
Why?
|
| Infant, Low Birth Weight | 1 | 2024 | 167 | 0.050 |
Why?
|
| Dipeptides | 1 | 2024 | 57 | 0.050 |
Why?
|
| Bestrophins | 1 | 2023 | 4 | 0.050 |
Why?
|
| Phenylalanine | 1 | 2024 | 128 | 0.050 |
Why?
|
| Software | 1 | 2008 | 684 | 0.050 |
Why?
|
| Guanine Nucleotide Dissociation Inhibitors | 1 | 2023 | 10 | 0.050 |
Why?
|
| Physical Exertion | 1 | 2013 | 78 | 0.050 |
Why?
|
| Malawi | 1 | 2024 | 398 | 0.050 |
Why?
|
| Genomics | 2 | 2023 | 1499 | 0.050 |
Why?
|
| Exome | 1 | 2018 | 1034 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2024 | 341 | 0.050 |
Why?
|
| Carbohydrates | 1 | 2022 | 34 | 0.050 |
Why?
|
| Apolipoprotein A-I | 1 | 2012 | 81 | 0.050 |
Why?
|
| Butyrates | 1 | 2022 | 35 | 0.050 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2022 | 25 | 0.050 |
Why?
|
| CD36 Antigens | 1 | 2012 | 37 | 0.050 |
Why?
|
| Homocysteine | 1 | 2023 | 123 | 0.050 |
Why?
|
| Survival Rate | 1 | 2017 | 2062 | 0.050 |
Why?
|
| Epistasis, Genetic | 1 | 2012 | 93 | 0.050 |
Why?
|
| Fibrinogen | 1 | 2023 | 156 | 0.050 |
Why?
|
| Interleukins | 1 | 2023 | 120 | 0.050 |
Why?
|
| Adipose Tissue, White | 1 | 2012 | 76 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 1117 | 0.050 |
Why?
|
| Prenatal Care | 1 | 2024 | 348 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 2894 | 0.050 |
Why?
|
| Logistic Models | 1 | 2016 | 1812 | 0.050 |
Why?
|
| Prevalence | 2 | 2021 | 2459 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2012 | 245 | 0.050 |
Why?
|
| Reading | 1 | 2012 | 79 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2011 | 398 | 0.040 |
Why?
|
| Memory, Short-Term | 1 | 2012 | 140 | 0.040 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2020 | 11 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 444 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2025 | 764 | 0.040 |
Why?
|
| Risk | 1 | 2012 | 756 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2020 | 208 | 0.040 |
Why?
|
| Antibodies, Bacterial | 1 | 2022 | 390 | 0.040 |
Why?
|
| Gambia | 1 | 2019 | 28 | 0.040 |
Why?
|
| Pregnancy | 2 | 2024 | 7209 | 0.040 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2019 | 18 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2020 | 187 | 0.040 |
Why?
|
| Length of Stay | 1 | 2025 | 1312 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 684 | 0.040 |
Why?
|
| Washington | 1 | 2019 | 32 | 0.040 |
Why?
|
| Horses | 1 | 2019 | 90 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2021 | 383 | 0.040 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2019 | 77 | 0.040 |
Why?
|
| Taiwan | 1 | 2018 | 31 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 3583 | 0.040 |
Why?
|
| Body Size | 1 | 2019 | 55 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 777 | 0.040 |
Why?
|
| Vitamin D Deficiency | 1 | 2019 | 73 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 2016 | 1050 | 0.040 |
Why?
|
| Thyroid Gland | 1 | 2019 | 104 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2019 | 203 | 0.040 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2018 | 14 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2019 | 156 | 0.040 |
Why?
|
| Serine Endopeptidases | 1 | 2019 | 180 | 0.040 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2018 | 100 | 0.040 |
Why?
|
| Anthropometry | 1 | 2019 | 197 | 0.040 |
Why?
|
| Phosphatidylethanolamine N-Methyltransferase | 1 | 2018 | 10 | 0.040 |
Why?
|
| Myosin-Light-Chain Phosphatase | 1 | 2017 | 5 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 2018 | 155 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 506 | 0.040 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2018 | 27 | 0.040 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2019 | 113 | 0.040 |
Why?
|
| Amidohydrolases | 1 | 2018 | 23 | 0.040 |
Why?
|
| Disease | 1 | 2019 | 129 | 0.040 |
Why?
|
| Seasons | 1 | 2019 | 312 | 0.040 |
Why?
|
| Contrast Media | 1 | 2021 | 480 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2025 | 1070 | 0.040 |
Why?
|
| Hypoxia | 1 | 2019 | 250 | 0.030 |
Why?
|
| ras Proteins | 1 | 2018 | 137 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2019 | 474 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2019 | 420 | 0.030 |
Why?
|
| Health Status | 1 | 2019 | 377 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 351 | 0.030 |
Why?
|
| Hospitalization | 1 | 2025 | 1789 | 0.030 |
Why?
|
| Neuroticism | 1 | 2016 | 4 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2019 | 339 | 0.030 |
Why?
|
| Texas | 1 | 2015 | 3588 | 0.030 |
Why?
|
| Schizophrenia | 1 | 2019 | 312 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2024 | 2107 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2018 | 314 | 0.030 |
Why?
|
| Cytokines | 1 | 2022 | 1289 | 0.030 |
Why?
|
| Disease Progression | 1 | 2012 | 2067 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2020 | 865 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 2019 | 345 | 0.030 |
Why?
|
| Actins | 1 | 2017 | 346 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 2018 | 251 | 0.030 |
Why?
|
| Diet, Fat-Restricted | 1 | 2015 | 40 | 0.030 |
Why?
|
| Curriculum | 1 | 2020 | 725 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2016 | 284 | 0.030 |
Why?
|
| Culture | 1 | 2015 | 67 | 0.030 |
Why?
|
| Psychological Tests | 1 | 2015 | 91 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2015 | 275 | 0.030 |
Why?
|
| Computational Biology | 1 | 2019 | 810 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 2914 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2018 | 798 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2020 | 1265 | 0.030 |
Why?
|
| Myocardium | 1 | 2019 | 1020 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 1113 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2015 | 278 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2018 | 1527 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2020 | 1181 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2012 | 4534 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2010 | 235 | 0.020 |
Why?
|
| Massachusetts | 1 | 2009 | 125 | 0.020 |
Why?
|
| Community Health Planning | 1 | 2009 | 9 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2009 | 93 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2020 | 1826 | 0.020 |
Why?
|
| Mice | 1 | 2024 | 17635 | 0.020 |
Why?
|
| Motivation | 1 | 2009 | 319 | 0.020 |
Why?
|
| Registries | 1 | 2009 | 1435 | 0.010 |
Why?
|